Select Medical (NYSE:SEM) Updates FY 2025 Earnings Guidance

Select Medical (NYSE:SEM) updated its FY 2025 earnings guidance on Thursday. The company provided earnings per share guidance of 1.090-1.190 for the period, compared to the consensus earnings per share estimate of 1.430. The company issued revenue guidance of $5.4 billion-$5.6 billion, compared to the consensus revenue estimate of $5.8 billion.

Analysts Set New Price Targets

A number of research firms recently weighed in on SEM. UBS Group cut their target price on shares of Select Medical from $40.00 to $21.00 and set a “neutral” rating on the stock in a research note on Friday, January 3rd. StockNews.com lowered shares of Select Medical from a “buy” rating to a “hold” rating in a research note on Thursday, February 13th. Benchmark lowered shares of Select Medical from a “buy” rating to a “hold” rating in a research note on Monday, November 25th. Finally, Royal Bank of Canada upped their target price on shares of Select Medical from $40.00 to $47.00 and gave the stock an “outperform” rating in a research note on Monday, November 4th. Three equities research analysts have rated the stock with a hold rating and two have given a buy rating to the company’s stock. According to data from MarketBeat, Select Medical has a consensus rating of “Hold” and an average price target of $39.50.

Select Medical Stock Down 0.8 %

Select Medical stock traded down $0.15 during mid-day trading on Thursday, hitting $19.11. The company had a trading volume of 975,271 shares, compared to its average volume of 792,814. The stock has a market cap of $2.47 billion, a price-to-earnings ratio of 8.93, a PEG ratio of 0.64 and a beta of 1.45. Select Medical has a 1 year low of $18.02 and a 1 year high of $40.98. The company has a quick ratio of 1.13, a current ratio of 1.13 and a debt-to-equity ratio of 1.37. The business has a fifty day moving average of $19.14 and a 200 day moving average of $28.14.

Select Medical (NYSE:SEM) last announced its quarterly earnings results on Thursday, February 20th. The health services provider reported $0.18 EPS for the quarter, missing the consensus estimate of $0.29 by ($0.11). Select Medical had a net margin of 3.97% and a return on equity of 15.99%. On average, sell-side analysts expect that Select Medical will post 1.97 earnings per share for the current fiscal year.

Insider Activity

In related news, VP Robert G. Breighner, Jr. sold 4,989 shares of Select Medical stock in a transaction on Wednesday, December 4th. The shares were sold at an average price of $19.95, for a total value of $99,530.55. Following the transaction, the vice president now directly owns 30,356 shares in the company, valued at $605,602.20. This trade represents a 14.12 % decrease in their position. The transaction was disclosed in a filing with the SEC, which is available at the SEC website. Also, Director Marilyn B. Tavenner sold 32,000 shares of Select Medical stock in a transaction on Tuesday, November 26th. The shares were sold at an average price of $21.09, for a total transaction of $674,880.00. Following the completion of the transaction, the director now owns 22,000 shares in the company, valued at approximately $463,980. This trade represents a 59.26 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Corporate insiders own 19.14% of the company’s stock.

Select Medical Company Profile

Select Medical Holdings Corporation, through its subsidiaries, operates critical illness recovery hospitals, rehabilitation hospitals, outpatient rehabilitation clinics, and occupational health centers in the United States. It operates in four segments: Critical Illness Recovery Hospital, Rehabilitation Hospital, Outpatient Rehabilitation, and Concentra.